Table 3.
Range of motion.
| UP1306 | Glucosamine and chondroitin combination | Placebo | p value | |||
|---|---|---|---|---|---|---|
| All three products | UP1306 versus G&C | UP1306 versus placebo | ||||
| Extension change from baseline to day 84 | 1.65 ± 2.43 (43) | 1.93 ± 3.16 (44) | 1.54 ± 1.89 (41) | 0.763 | 0.445 | 0.683 |
| 0 (−1–10) | 0 (−2–14) | 2 (−2–6) | ||||
| p < 0.001∗ | p < 0.001∗ | p < 0.001∗ | ||||
|
| ||||||
| Flexion change from baseline to day 84 | −8.3 ± 7.1 (43) | −8.0 ± 8.2 (44) | −7.8 ± 8.2 (41) | 0.944 | 0.867 | 0.930 |
| −8 (−25–8) | −6 (−25–4) | −6 (−32–7) | ||||
| p < 0.001∗ | p < 0.001∗ | p < 0.001∗ | ||||
∗Significant: p ≤ 0.05.